Skip to main content
logo
Aytu BioPharma, Inc. (AYTU)
NASDAQ: AYTU · Real-Time Price · USD
2.630
+0.050 (1.94%)
At close: May 1, 2026, 4:00 PM EDT
2.610
-0.020 (-0.76%)
After-hours: May 1, 2026, 4:10 PM EDT

Aytu BioPharma Revenue

Aytu BioPharma had revenue of $15.17M in the quarter ending December 31, 2025, a decrease of -6.51%. This brings the company's revenue in the last twelve months to $62.64M, up 2.00% year-over-year. In the fiscal year ending June 30, 2025, Aytu BioPharma had annual revenue of $66.38M with 1.84% growth.

Revenue (ttm)
$62.64M
Revenue Growth
+2.00%
P/S Ratio
0.45
Revenue / Employee
$754,699
Employees
83
Market Cap
28.01M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Jun 30, 202566.38M1.20M1.84%
Jun 30, 202465.18M-42.22M-39.31%
Jun 30, 2023107.40M10.73M11.10%
Jun 30, 202296.67M31.04M47.29%
Jun 30, 202165.63M38.00M137.52%
Jun 30, 202027.63M--
Jun 30, 2019---
Jun 30, 20183.66M-2.78M-43.19%
Jun 30, 20176.44M--
Jun 30, 2016---
Jun 30, 2015261.78K202.85K344.23%
Jun 30, 201458.93K8.93K17.86%
Jun 30, 201350.00K48.25K2,757.14%
Aug 31, 20121.75K--
Aug 31, 2011---
Aug 31, 2010---
Aug 31, 20091.75K--
Aug 31, 2008---
Aug 31, 2007---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
InterCure84.76M
Rockwell Medical69.26M
BGM Group25.10M
Zhengye Biotechnology Holding16.64M
China Pharma Holdings4.14M
TherapeuticsMD3.02M
Akanda836.66K
BioXcel Therapeutics642.00K
Revenue Rankings

AYTU News

More News